These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2832858)

  • 21. The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Sep; 52(1):19-26. PubMed ID: 4281339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unit activity in the dorsal raphe in freely-moving cats. Effect of monoamine oxidase inhibitors.
    Trulson ME; Trulson VM
    Neuropharmacology; 1985 Jun; 24(6):473-8. PubMed ID: 2410806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulatory effect of p-chlorophenylalanine microinjected into the dorsal and median raphe nuclei on cocaine-induced behaviour in the rat.
    Herges S; Taylor DA
    Eur J Pharmacol; 1999 Jun; 374(3):329-40. PubMed ID: 10422777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motor effects of serotonin in the central nervous system.
    Gerson SC; Baldessarini RJ
    Life Sci; 1980 Oct; 27(16):1435-51. PubMed ID: 6160367
    [No Abstract]   [Full Text] [Related]  

  • 26. The involvement of brain serotonin in the clonidine-induced hypothermia in rats.
    Płaźnik A; Kostowski W; Danysz W
    Pol J Pharmacol Pharm; 1983; 35(4):301-8. PubMed ID: 6320143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressant monoamine oxidase inhibitors enhance serotonin but not norepinephrine neurotransmission.
    Blier P; de Montigny C
    Psychopharmacol Ser; 1987; 3():127-34. PubMed ID: 3029752
    [No Abstract]   [Full Text] [Related]  

  • 28. Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats.
    Maki Y; Inoue T; Izumi T; Muraki I; Ito K; Kitaichi Y; Li X; Koyama T
    Eur J Pharmacol; 2000 Oct; 406(3):411-8. PubMed ID: 11040348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apomorphine and central serotonin neurons.
    Grabowska M; Antkiewicz L; Maj J; Michaluk J
    Pol J Pharmacol Pharm; 1973; 25(1):29-39. PubMed ID: 4272897
    [No Abstract]   [Full Text] [Related]  

  • 31. Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice.
    Villégier AS; Salomon L; Blanc G; Godeheu G; Glowinski J; Tassin JP
    Eur J Neurosci; 2006 Sep; 24(5):1359-65. PubMed ID: 16965547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neurotransmission.
    Andrews AM; Murphy DL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1432-9. PubMed ID: 8263805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of the elimination half-life of the monoamine oxidase inhibitor cimoxatone in rat brain on the basis of ex vivo inhibition data.
    Fowler CJ; Strolin Benedetti M; Rovei V
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):389-93. PubMed ID: 6673976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactions.
    Tipton KF; Fowler CJ; McCrodden JM; Strolin Benedetti M
    Biochem J; 1983 Jan; 209(1):235-42. PubMed ID: 6847610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine.
    Trulson ME; Eubanks EE; Jacobs BL
    J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of two different reversible monoamine oxidase-A inhibitors on nociceptive thresholds in the rat.
    Bianchi M; Mantegazza P; Panerai AE
    Eur J Pharmacol; 1992 Aug; 219(1):113-6. PubMed ID: 1397038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
    Colzi A; D'Agostini F; Cesura AM; Borroni E; Da Prada M
    J Pharmacol Exp Ther; 1993 Apr; 265(1):103-11. PubMed ID: 8473998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological studies on serotonin-mediated behaviour.
    Green AR
    J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiolytic and memory improving effects of moclobemide.
    Nowakowska E; Chodera A; Kus K; Rybakowski J
    Arzneimittelforschung; 1998 Jun; 48(6):625-8. PubMed ID: 9689417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.